SOD has also been associated with albuminuria; downregulation of renal SOD1 and SOD3 was observed in progressive DN [129], and finerenone, a novel non-steroidal mineralocorticoid receptor antagonist, achieved an increase in renal SOD activity and a reduction in albuminuria in CKD animal models [130]. This evidence concerns the gene SOD1 and liver dysplastic nodule.